Cardiotrophin-like cytokine-1 (CLC-1) and soluble urokinase plasminogen activator surface receptor (suPAR) are implicated in the pathogenesis of FSGS [31,32]. The gene discussed is CLCN1; the disease is focal segmental glomerulosclerosis.